Recent Updates
Recently added Catalysts
BLCO Positive Sentiment

Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28

Monday, October 5, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Bausch + Lomb Corporation will release its third-quarter financial results on October 28, 2026. The company plans to host a conference call and live webcast at 8 a.m. ET to discuss these results and provide a business update. All relevant materials will be available on their Investor Relations website prior to the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bausch + Lomb is committed to transparency with its financial results.
  • The upcoming conference call will provide valuable insights for investors.
  • The company continues to focus on its mission of improving eye health.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
1.4%
average across 3 past catalysts
Lead asset
brinzolamide 1%
Phase 3 · Glaucoma

Full Press Release Details

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter financial results on Wednesday, Oct. 28, 2026. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the c

Frequently Asked Questions

When will Bausch + Lomb release its Q3 2026 results?

Bausch + Lomb will release its Q3 2026 financial results on October 28, 2026.

What time is the Bausch + Lomb conference call?

The conference call will take place at 8 a.m. ET on October 28, 2026.

Where can I find the financial results materials?

All materials will be available on the Investor Relations section of the Bausch + Lomb website.

What is the purpose of the conference call?

The conference call will discuss the financial results and provide a business update.

ShareAdd on Google
Tags: BLCO Bausch + Lomb financial results Q3 2026 conference call
Last updated: Oct 5, 2026

Biotech snapshot

Cash runway
$367M liquidity · $0M/mo burn
Low dilution risk
Lead asset
brinzolamide 1%Phase 3
Glaucoma →

Catalyst track record

+13%
best trade around BLCO's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for BLCO.

See every catalyst's timing & PoA →